Immunotherapy: Hyperprogression and Treatment Beyond Progression

被引:1
|
作者
Gandara, D. [1 ]
机构
[1] Univ Calif Davis, Ctr Comprehens Canc, Sacramento, CA USA
关键词
HPD/FP; TBP; CPI;
D O I
10.1016/j.jtho.2019.08.195
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
GR02.04
引用
收藏
页码:S85 / S85
页数:1
相关论文
共 50 条
  • [1] Hyperprogression: A Unique Phenomenon of Progression of Existing Tumor Secondary to Immunotherapy
    Mandal, Shobha
    Ray, Barun
    Sharma, Srijana Baniya
    Poulose, Joyson
    Kasireddy, Vineela
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (09)
  • [2] Hyperprogression during immunotherapy
    Isobel Leake
    [J]. Nature Cancer, 2023, 4 : 1640 - 1640
  • [3] Hyperprogression during immunotherapy
    Leake, Isobel
    [J]. NATURE CANCER, 2023, 4 (12) : 1640 - 1640
  • [4] Hyperprogression after immunotherapy
    Abbas, Waseem
    Rao, Ranga Raju
    Popli, Swati
    [J]. SOUTH ASIAN JOURNAL OF CANCER, 2019, 8 (04) : 244 - 246
  • [5] Hyperprogression under Immunotherapy
    Frelaut, Maxime
    Le Tourneau, Christophe
    Borcoman, Edith
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (11)
  • [6] Hyperprogression with immunotherapy: Is it real?
    Popat, Sanjay
    [J]. CANCER, 2019, 125 (08) : 1218 - 1220
  • [7] Hyperprogression in advanced melanoma is not restricted to immunotherapy
    Fournier, Marie
    Mortier, Laurent
    Dereure, Olivier
    Dalac, Sophie
    Oriano, Bastien
    Dalle, Stephane
    Lebbe, Celeste
    [J]. EUROPEAN JOURNAL OF CANCER, 2023, 193
  • [8] Hyperprogression after immunotherapy: A comprehensive review
    Cakir, Muharrem Okan
    Kirca, Onder
    Gunduz, Seyda
    Ozdogan, Mustafa
    [J]. JOURNAL OF BUON, 2019, 24 (06): : 2232 - 2241
  • [9] Hyperprogression in advanced melanoma is not restricted to immunotherapy
    Yang, Fan
    Xu, Nan
    [J]. EUROPEAN JOURNAL OF CANCER, 2024, 199
  • [10] Hyperprogression as a distinct outcome after immunotherapy
    Fuentes-Antras, J.
    Provencio, M.
    Diaz-Rubio, E.
    [J]. CANCER TREATMENT REVIEWS, 2018, 70 : 16 - 21